These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35347537)

  • 1. Identification of Potential Biomarkers in the Peripheral Blood Mononuclear Cells of Relapsing-Remitting Multiple Sclerosis Patients.
    Golabi M; Fathi F; Samadi M; Hesamian MS; Eskandari N
    Inflammation; 2022 Aug; 45(4):1815-1828. PubMed ID: 35347537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
    Mosarrezaii Aghdam A; Rezaei S; Zarza Nalivan F; Babaie F; Amiri Nikpour MR; Torkamandi S
    Immunol Invest; 2022 Jul; 51(5):1149-1161. PubMed ID: 33866949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers.
    Mohammadinasr M; Montazersaheb S; Molavi O; Kahroba H; Talebi M; Ayromlou H; Hejazi MS
    Neuromolecular Med; 2023 Sep; 25(3):402-414. PubMed ID: 37020076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study.
    Zanghì A; Manuti V; Serviddio G; D'Amico E; Avolio C
    Front Immunol; 2023; 14():1226130. PubMed ID: 37711630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential microRNA expression in blood in multiple sclerosis.
    Søndergaard HB; Hesse D; Krakauer M; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Dec; 19(14):1849-57. PubMed ID: 23773985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
    Gandhi R; Healy B; Gholipour T; Egorova S; Musallam A; Hussain MS; Nejad P; Patel B; Hei H; Khoury S; Quintana F; Kivisakk P; Chitnis T; Weiner HL
    Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of potential microRNA biomarkers for multiple sclerosis.
    Al-Temaimi R; Alshammari N; Alroughani R
    Exp Mol Pathol; 2024 Jun; 137():104903. PubMed ID: 38772208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Expression Levels of miR-29b-3p and miR-326 in T Helper-1 and T Helper-17 Cells Isolated from Responsive and Non-responsive Relapsing-remitting Multiple Sclerosis Patients Treated with Interferon-beta.
    Karimi L; Eskandari N; Shaygannejad V; Zare N; Andalib A; Khanahmad H; Mirmosayyeb O
    Iran J Allergy Asthma Immunol; 2020 Aug; 19(4):416-425. PubMed ID: 33463108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of plasma Osteopontin level in relapsing- remitting multiple sclerosis patients compared to healthy subjects in Isfahan Province.
    Jafarinia M; Sadeghi E; Alsahebfosoul F; Etemadifar M; Jahanbani-Ardakani H
    Int J Neurosci; 2020 May; 130(5):493-498. PubMed ID: 31795798
    [No Abstract]   [Full Text] [Related]  

  • 10. MicroRNAs Correlate with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in a Chinese Population.
    Chen J; Zhu J; Wang Z; Yao X; Wu X; Liu F; Zheng W; Li Z; Lin A
    Med Sci Monit; 2017 May; 23():2565-2583. PubMed ID: 28550707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic protease activating factor-1 gene and MicroRNA-484: A possible interplay in relapsing remitting multiple sclerosis.
    Mohamed DAW; Selim HM; Elmazny A; Genena A; Nabil MM
    Mult Scler Relat Disord; 2022 Feb; 58():103502. PubMed ID: 35030371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study.
    Sağır F; Ersoy Tunalı N; Tombul T; Koral G; Çırak S; Yılmaz V; Türkoğlu R; Tüzün E
    Genet Test Mol Biomarkers; 2021 Nov; 25(11):720-726. PubMed ID: 34788141
    [No Abstract]   [Full Text] [Related]  

  • 13. Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients.
    Arisi I; Malimpensa L; Manzini V; Brandi R; Gosetti di Sturmeck T; D'Amelio C; Crisafulli S; Ferrazzano G; Belvisi D; Malerba F; Florio R; Pascale E; Soreq H; Salvetti M; Cattaneo A; D'Onofrio M; Conte A
    Front Immunol; 2023; 14():1234869. PubMed ID: 38152407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miR-34a-5p, miR-103a-3p, and miR-376a-3p as possible biomarkers of conversion from relapsing-remitting to secondary progressive multiple sclerosis.
    Agostini S; Mancuso R; Citterio LA; Caputo D; Oreni L; Nuzzi R; Pasanisi MB; Rovaris M; Clerici M
    Neurobiol Dis; 2024 Oct; 200():106648. PubMed ID: 39181188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of mir-301a in PBMCs of patients with relapsing-remitting multiple sclerosis is associated with reduced NKRF and PIAS3 expression levels and disease activity.
    Tavakolpour V; Shokri G; Naser Moghadasi A; Mozafari Nahavandi P; Hashemi M; Kouhkan F
    J Neuroimmunol; 2018 Dec; 325():79-86. PubMed ID: 30316680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
    Groen K; Maltby VE; Lea RA; Sanders KA; Fink JL; Scott RJ; Tajouri L; Lechner-Scott J
    BMC Med Genomics; 2018 May; 11(1):48. PubMed ID: 29783973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-9-5p and miR-106a-5p dysregulated in CD4
    Majd M; Hosseini A; Ghaedi K; Kiani-Esfahani A; Tanhaei S; Shiralian-Esfahani H; Rahnamaee SY; Mowla SJ; Nasr-Esfahani MH
    Iran J Basic Med Sci; 2018 Mar; 21(3):277-283. PubMed ID: 29511494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis.
    Selmaj I; Cichalewska M; Namiecinska M; Galazka G; Horzelski W; Selmaj KW; Mycko MP
    Ann Neurol; 2017 May; 81(5):703-717. PubMed ID: 28411393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.
    Ahmadian-Elmi M; Bidmeshki Pour A; Naghavian R; Ghaedi K; Tanhaei S; Izadi T; Nasr-Esfahani MH
    Immunogenetics; 2016 Jan; 68(1):43-54. PubMed ID: 26563334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-155 and functional proteins of CD8+ T cells as potential prognostic biomarkers for relapsing-remitting multiple sclerosis.
    Elkhodiry AA; Zamzam DA; El Tayebi HM
    Mult Scler Relat Disord; 2021 Aug; 53():103078. PubMed ID: 34171684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.